Ascension Sacred Heart Bay held a ribbon-cutting and a blessing on Monday for a brand-new mobile PET scan machine. The new ...

Burlingame, CA, Oct. 08, 2025 (GLOBE NEWSWIRE) -- The Global CT Scanner Market is estimated to be valued at USD 9.15 Bn in 2025 and is expected to reach USD 14.03 Bn by 2032, exhibiting a compound ...

The growing use of GLP-1 receptor agonists may affect the interpretation of oncological FDG PET-CT scans, new research presented today at the 38th Annual Congress of the European Association of ...

The rise of GLP-1 receptor agonist drugs prescribed for weight loss and type 2 diabetes could be compromising the interpretation of some cancer scans and throwing doctors off course. This is the ...

(Barcelona, Spain, Wednesday 8 September 2025) The growing use of GLP-1 receptor agonists may affect the interpretation of oncological FDG PET-CT scans, new research presented today at the 38th Annual ...

Originally published on talker.news, part of the BLOX Digital Content Exchange .

NASHVILLE, Tenn. (WSMV) - Surgeons at Vanderbilt University Medical Center (VUMC) were the first in the country to use brand-new technology during a surgery that they are hoping will soon be at the ...

A new “unusual” side effect of weight-loss drugs is becoming more common, research has suggested. Weight-loss drugs such as Ozempic and Wegovy have soared in popularity. About one in eight U.S. adults ...

Game-changing weight loss jabs relied on by millions of slimmers and diabetics could cause certain cancer scans to be less effective, experts have suggested. The drugs, which include Mounjaro and ...

A new scandal involving CT scanners in the sports card industry! Plus, mailbag reveals and a preview of the National Convention. Trump’s push to rewrite the history of January 6 takes an especially ...

KNOXVILLE, Tenn. (WATE) — Pet microchip scanners have been installed at two Knoxville fire stations in an effort to expedite the return of lost pets to their homes. Station 3, located at 204 E. Baxter ...

Researchers have revealed a surprising new side effect linked to GLP-1 agonists, such as Ozempic, Wegovy, Mounjaro and Zepbound. These popular treatments for diabetes and obesity could interfere with ...